Gilead Sciences’ (GILD) “Sector Perform” Rating Reaffirmed at Royal Bank of Canada
Gilead Sciences (NASDAQ:GILD – Get Free Report)‘s stock had its “sector perform” rating reissued by equities researchers at Royal Bank of Canada in a note issued to investors on Wednesday,Benzinga reports. They presently have a $84.00 target price on the biopharmaceutical company’s stock. Royal Bank of Canada’s target price points to a potential downside of […]
More Stories
Insider Selling: Vital Farms, Inc. (NASDAQ:VITL) Insider Sells $916,560.00 in Stock
Vital Farms, Inc. (NASDAQ:VITL – Get Free Report) insider Matthew Ohayer sold 24,000 shares of the firm’s stock in a...
AppLovin Co. (NASDAQ:APP) Insider Sells $5,000,040.97 in Stock
AppLovin Co. (NASDAQ:APP – Get Free Report) insider Victoria Valenzuela sold 15,971 shares of the business’s stock in a transaction...
Nutanix, Inc. (NASDAQ:NTNX) Director Sells $392,263.80 in Stock
Nutanix, Inc. (NASDAQ:NTNX – Get Free Report) Director Virginia Gambale sold 6,060 shares of the business’s stock in a transaction...
Top 10 Dive Watch for 2025
Searching for the right dive watch to accompany you or enhance your style during water activities in 2025? Trust dive...
Easterly Government Properties, Inc. (NYSE:DEA) CEO Buys $109,100.00 in Stock
Easterly Government Properties, Inc. (NYSE:DEA – Get Free Report) CEO Darrell W. Crate purchased 10,000 shares of the business’s stock...
Insider Buying: Calian Group Ltd. (TSE:CGY) Director Purchases 500 Shares of Stock
Calian Group Ltd. (TSE:CGY – Get Free Report) Director George Brian Weber acquired 500 shares of the company’s stock in...